Zymeworks Inc.

ZYME · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$20$2-$23-$24
Dep. & Amort.$3$3$3$4
Deferred Tax-$0$0-$0$1
Stock-Based Comp.$7$6$6$5
Change in WC-$21-$0$10-$27
Other Non-Cash-$0$1-$0-$1
Operating Cash Flow-$31$12-$3-$42
Investing Activities
PP&E Inv.-$0-$1-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$35-$70-$34-$54
Inv. Sales/Matur.$36$80$47$48
Other Inv. Act.$0-$0-$0$0
Investing Cash Flow$0$9$12-$6
Financing Activities
Debt Repay.$0$0$0-$0
Stock Issued$0$1$0$0
Stock Repurch.$0$0$0-$9
Dividends Paid$0$0$0$0
Other Fin. Act.-$2-$0$1$1
Financing Cash Flow-$2$1$1-$9
Forex Effect$0-$0$0$0
Net Chg. in Cash-$33$22$10-$56
Supplemental Information
Beg. Cash$98$76$66$122
End Cash$65$98$76$66
Free Cash Flow-$32$11-$4-$42
Zymeworks Inc. (ZYME) Financial Statements & Key Stats | AlphaPilot